PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
CAMK2A 42 Target Target CAMK2B 21 2 0.07 -0.93 0.10 0.83
EPHA4 357 Target Target EPHB2 385 25 0.07 -0.93 0.07 0.82
BD2 76 Target Target BD4 26 3 0.07 -0.92 0.12 0.82
Alpha-Glucosidase 4,319 Target Target Alpha-Amylase 7,171 376 0.07 -0.93 0.09 0.77
CNTF 1,613 Target Target Cardiotrophin-1 351 51 0.07 -0.91 0.15 0.78
CNTF 1,613 Target Target BDNF 11,163 292 0.07 -0.89 0.18 0.75
CCL7 274 Target Target CCL1 220 17 0.07 -0.93 0.08 0.82
CCL3 1,427 Target Target CCL1 220 39 0.07 -0.89 0.18 0.78
ELC 355 Target Target Exodus-2 27 7 0.07 -0.85 0.26 0.79
CCL5 2,002 Target Target CCL8 197 45 0.07 -0.87 0.23 0.78
CCL3 1,427 Target Target CCL8 197 38 0.07 -0.89 0.19 0.78
Epidermal Growth Factor Receptor 24,772 Target Target Erbb2 4,536 770 0.07 -0.90 0.17 0.74
C5a 4,164 Target Target C4A 1,177 161 0.07 -0.91 0.14 0.78
CCL5 2,002 Target Target CXCL11 526 75 0.07 -0.91 0.14 0.79
Thromboembolism 23,698 Disease Target D-Dimer 6,185 887 0.07 -0.91 0.14 0.75
CCL14 34 Target Target CCL8 197 6 0.07 -0.89 0.18 0.81
APOA1 958 Target Target APOA2 118 25 0.07 -0.88 0.21 0.79
Cytokeratin 8 587 Target Target Cytokeratin 18 1,108 60 0.07 -0.92 0.10 0.81
CD14 9,941 Target Target Endotoxin receptor 115 80 0.07 -0.55 0.70 0.74
CCL7 274 Target Target CXCL2 750 34 0.08 -0.91 0.12 0.81
Acute Coronary Syndromes 9,133 Disease Target Eptifibatide 772 200 0.08 -0.85 0.26 0.75
CXCL10 2,386 Target Target CCL8 197 52 0.08 -0.85 0.26 0.77
Deep Vein Thrombosis 10,952 Disease Target D-Dimer 6,185 630 0.08 -0.92 0.10 0.77
AACT 109 Target Target Alpha-1 AntiChymotrypsin 1,460 31 0.08 -0.84 0.28 0.78
Alpha-2a Adrenergic Receptor 188 Target Target Alpha-2c Adrenergic Receptor 42 7 0.08 -0.90 0.17 0.82
ELC 355 Target Target Ck-beta-11 4 3 0.08 -0.50 0.75 0.78
EPHA4 357 Target Target EPHA3 140 18 0.08 -0.91 0.13 0.82
DAPK2 27 Target Target DAPK1 205 6 0.08 -0.87 0.22 0.81
CCL7 274 Target Target CCL5 2,002 60 0.08 -0.87 0.22 0.79
CCL7 274 Target Target CCL3 1,427 51 0.08 -0.89 0.19 0.79
CA 72-4 184 Target Target CA 15-3 898 34 0.08 -0.89 0.18 0.80
Des (1-3) IGF-I 191 Target Target Des (1-6) IGF-II 18 5 0.09 -0.84 0.28 0.81
Epiregulin 291 Target Target beta-Cellulin 17 6 0.09 -0.80 0.35 0.80
CXCL7 76 Target Target CXCL3 145 9 0.09 -0.91 0.12 0.84
CD1A 2,739 Target Target CD14 9,941 456 0.09 -0.89 0.17 0.77
Eotaxin 2,457 Target Target Eotaxin-2/CCL24 19 19 0.09 -0.22 1.00 0.76
CKMM 55 Target Target CKBB 57 5 0.09 -0.91 0.09 0.86
Mu Opioid Receptor 4,576 Target Target Opioid Receptor Mu 71 51 0.09 -0.53 0.72 0.76
Epigen 27 Target Target Epiregulin 291 8 0.09 -0.83 0.30 0.81
FABP3 134 Target Target FABP1 90 10 0.09 -0.91 0.11 0.84
EPHB4 329 Target Target EPHB3 118 18 0.09 -0.90 0.15 0.82
Platelet Aggregation 25,460 Disease Target Collagen 138,882 5,467 0.09 -0.87 0.21 0.72
ELC 355 Target Target Exodus-3 8 5 0.09 -0.61 0.62 0.79
CCL4 5,638 Target Target CCL5 2,002 316 0.09 -0.89 0.16 0.79
Obesity 138,233 Disease Target Adiponectin 11,994 3,886 0.10 -0.81 0.32 0.72
EPHB4 329 Target Target EPHB2 385 34 0.10 -0.90 0.10 0.84
Ck-beta-11 4 Target Target Exodus-2 27 1 0.10 -0.85 0.25 0.84
CCN5 57 Target Target CYR61 539 17 0.10 -0.82 0.30 0.81
CXCL9 1,016 Target Target CCL3 1,427 117 0.10 -0.90 0.12 0.82
Ent2 108 Target Target Equilibrative Nucleoside Transporter 1 211 15 0.10 -0.89 0.14 0.84